Press Releases

We are pleased to announce a strategic collaboration with Evidence Matters, a pioneer in clinical trial data science and document engineering. Evidence Matter’s RegulatoryFlow platform, and specialized services unify clinical data and documents, simplify workflows and accelerate the work of key life sciences professionals, from medical writers to regulatory specialists.

Altasciences have been chosen by Steel Therapeutics, Inc. for their pivotal toxicology study for Fizurex™, a novel compounded topical wipe. The study is currently underway at our preclinical facility.

Altasciences is partnering with VoxCell BioInnovation, a leader in 3D bioprinting and human-like tissue modeling, to enhance preclinical research and accelerate the path from discovery to clinical trials.

Altasciences is proud to announce they have been awarded a 2025 CDMO Leadership Award in the Small Molecule Dosage Form–North America category.

Altasciences is committed to providing world-class bioanalytical services in support of the preclinical and clinical studies conducted at our cutting-edge facilities, as well as extensive standalone solutions to meet your diverse needs. Our flexible bioanalytical services from discovery to Phase IV empower our clients across every phase of research.